Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?

OBJECTIVES:. To examine whether interleukin-6 in critical coronavirus disease 2019 is higher in arterial than in central venous blood, as a sign of predominantly local pulmonal rather than systemic interleukin-6 production. DESIGN:. Prospective cohort pilot study with repeated weekly measurements of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nikolai Ravn Aarskog, MD, Hans Christian Aass, PhD, Jan Cato Holter, MD, PhD, Morten Rostrup, MD, PhD, Aleksander Rygh Holten, MD, PhD
Format: article
Langue:EN
Publié: Wolters Kluwer 2021
Sujets:
Accès en ligne:https://doaj.org/article/77ff7ef076ce42c0bd7b814e4a482e9c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!